论文部分内容阅读
潜江制药股份有限公司,叶继革、刘强、刘德山、黄祥平、张贤圣、李献海、肖王利玲、王仁祥、曾凡波、王永海、王凯:按照《上市公司检查办法》的规定,中国证监会于2001年9月对潜江制药股份有限公司募股资金使用的有关问题进行了专项核查。检查发现,2001年7月16日至9月20日期间,潜江制药股份有限公司未经董事会、股东大会决策及批准,擅自挪用募集资金2.2亿元购买国
Qianjiang Pharmaceutical Co., Ltd. In accordance with the “Measures for the Inspection of Listed Companies”, the China Securities Regulatory Commission in 2001 In September, the Company conducted a special inspection on the relevant issues concerning the use of proceeds from the offering of shares in Qianjiang Pharmaceutical Co., Ltd. Inspection found that, from July 16, 2001 to September 20, 2001, Qianjiang Pharmaceutical Co., Ltd. without the board of directors, shareholders’ general meeting of decision-making and approval, unauthorized use of funds raised 220 million yuan to buy the country